Jussi M.M. Palomäki
jussipalomaki.bsky.social
Jussi M.M. Palomäki
@jussipalomaki.bsky.social
The first night of #woa2025 looked surreal (see the photo). Thankfully yesterday was kind sunny and the weather today also looks promising…
August 1, 2025 at 1:14 PM
I will present my latest results at the poster session in the IHW2025 today. users.utu.fi/jmmpal/2025/...
July 27, 2025 at 12:14 PM
I will be attending the 49th Annual International Herpesvirus Workshop Conference in Berlin, Germany at 27. July to present my poster. users.utu.fi/jmmpal/2025/...
July 22, 2025 at 8:17 AM
My train was late, so I had to find a place to spend time at Tampere. Rookies (rookies.fi) was a nice one. (Not that anyone reads my Bluesky anyway, but still…🤓)
Etusivu - Rookies sportsbar
Rookie's ravintola on tyylikkäästi sporttinen ruoka- ja juomaravintola Tampereen keskustassa, rautatieaseman kupeessa.
rookies.fi
July 18, 2025 at 5:42 PM
Just saw an interesting presentation about a potential link between viruses and neurodegenerative disease. Not my field specifically, but interesting nevertheless. www.science.org/doi/10.1126/...
SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity
Viral infection and the expression of viral fusogens in the nervous system drive neuronal fusion compromising neuronal activity.
www.science.org
February 7, 2025 at 11:56 AM
Come and check my poster at the Virology Days 2025 Conference in Jyväskylä. users.utu.fi/jmmpal/2025/...
Virology Days 2025 Conference | Jussi Palomäki
My poster "HSV VECTOR EXPRESSING A VARIANT OF HAS2 GENE EXHIBITS ENHANCED ONCOLYTIC EFFECT AND TUMOR SUPPRESSOR RESPONSE" is presented at the Viro ...
users.utu.fi
February 6, 2025 at 4:09 AM
We have developed an HSV vector expressing human decorin gene. Our first results of its efficacy in lung adenocarcinoma cells have been published: onlinelibrary.wiley.com/doi/10.1002/...
Decorin Expressed From Herpes Simplex Virus Vector Improves Oncolytic Efficacy in Lung Adenocarcinoma Cells
Decorin (DCN) is a small extracellular proteoglycan with significant oncosuppressive activity. Lung adenocarcinoma is commonly devoid of DCN expression and is a leading cause of cancer mortality glob...
onlinelibrary.wiley.com
January 14, 2025 at 9:03 PM